Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer is a research paper published in Frontiers in Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 82 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: F30 CA236031
National Institutes of Health
Grant: 5F30CA236031-02
Augmenting Pancreatic Cancer Immunotherapy via TGFβ Pathway Inhibition
U.S. Department of Veterans Affairs
National Cancer Institute
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Influence network model uncovers relations between biological processes and mutational signatures
Additional file 1 of Influence network model uncovers relations between biological processes and mutational signatures